Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

FIMRC Fundraiser x Parasites Without Borders Kicks Off This Spring

Throughout May, June, and July, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to Foundation for International Medical Relief of Children (FIMRC), for a total gift of up to $10,000. Founded in 2002 by Dr. Vikram D. Bakhru, FIMRC is a U.S.-based nonprofit organization that works to improve access to care through innovative, self-sustaining health programs. FIMRC works alongside communities to improve health from the ground up — including building necessary infrastructure, such as constructing or updating buildings; ensuring communities have access to a healthcare professional; and educating on preventive health.
Learn more at
fimrc.org

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

Corona Vaccine

May 5, 2024

COVID-19 Booster Vaccine Uptake and Reduced Risks for Long-COVID | COVID-19 Immunologic Antiviral Therapy with Omalizumab (CIAO)—a Randomized Controlled Clinical Trial | Abatacept Pharmacokinetics and Exposure Response in Patients | The Gut Microbiome Associates with Phenotypic Manifestations | Characteristics and Determinants of Pulmonary Long COVID | Long COVID: Plasma Levels of Neurofilament Light Chain in Mild COVID-19 Patients with Neurocognitive Symptoms
Corona Vaccine In Childrens

April 24, 2024

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023 | Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen | The Persistence of SARS-CoV-2 in Tissues and its Association with Long COVID Symptoms: A Cross-sectional Cohort Study in China
Impact of SARS-CoV-2

April 17, 2024

Systematic Analyses of the Factors Influencing Sperm Quality in Patients with SARS-CoV-2 Infection | Nirmatrelvir/ritonavir and Remdesivir against Symptomatic Treatment in High-risk COVID-19 Outpatients to Prevent Hospitalization or Death During the Omicron Era: A Propensity Score-matched Study | Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
Corona Vaccine in Rural Area

April 11, 2024

Rural-urban Differences in Long-term Mortality and Readmission Following COVID-19 Hospitalization | Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with COVID-19 | Brain and Cognitive Changes in Patients with Long COVID Compared with Infection-recovered Control Subjects | Incident Allergic Diseases in Post-COVID-19 Condition: Multinational Cohort Studies from South Korea, Japan and the UK | Functional Limitations and Exercise Intolerance in Patients with Post-COVID Condition
Covid Phase

April 3, 2024

Interplay of Inflammatory Markers and Anti-SARS-CoV-2 Antibodies in COVID-19 | Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease | Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs | Paxlovid Use is Associated with Lower Risk of Cardiovascular Diseases in COVID-19 Patients with Autoimmune Rheumatic Diseases
Covid Treatment

March 28, 2024

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment - A Randomized Clinical Trial | Joint Analysis of Vaccination Effectiveness and Antiviral Drug Effectiveness for COVID-19: A Causal Inference Approach | Timing and Predictors of Loss of Infectivity Among Healthcare Workers with Mild Primary and Recurrent COVID-19: A Prospective Observational Cohort Study | Household Transmission Dynamics of Asymptomatic SARS-CoV-2–Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study

Situation Dashboards

World_Health_Organization_logo_logotype

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)
university-logo-small-horizontal-blue-no-clear-space-51c7fb4524

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU
1point3acres

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources
image

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

Sources for COVID-19 Information

World_Health_Organization_logo_logotype

World Health Organization (WHO)

U.S. Centers for Disease Control and Prevention

Centers for Disease Control, US

International Society for Infectious Diseases

International Society for Infectious Diseases

twiv-logo

This Week in Virology (TWIV)

Row triangle Shape Decorative svg added to bottom

Learn more about parasitic diseases and receive updates about Parasites Without Borders' initiatives and developments by subscribing to our newsletter.

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders Today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top